MARATTO

article · Minia Journal of Medical Research

Value of N-terminal proBNP in patients with mitral stenosis

2024Open accessMinia University

Abstract

Introduction: Mitral valve stenosis (MS) is an important valvular disorder in developing countries. N-terminal part of pro B type natriuretic peptide (NT-proBNP) has been used as a diagnostic and/or prognostic biomarker for clinical outcomes in some cardiac disorders.Aim: To show the association between NT-proBNP levels and hemodynamic variables in mitral stenosis patients.Patients and methods: Forty six patients with severe MS and sinus heart rhythm and twenty five healthy individuals as a control group were enrolled and NT-proBNP levels were assessed in them.Results: Mitral stenosis patients have higher levels of NT-proBNP in comparison of the control subjects. The severity of dyspnea was correlated with NT-proBNP levels. Also, left atrial size and pulmonary arterial pressure were significantly related to NT-proBNP levels. Conclusion: NT-proBNP is increased in MS patients and is associated with clinical and haemodynamic variables. Therefore, NT-proBNP may be used as a complementary variable with the clinical and echocardiographic evaluations in MS patients.Keywords: Mitral stenosis, NT- proBNP.

Research topics

  • Cardiac Valve Diseases and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/mjmr.2024.257417.1573

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.